Salix media coverage and headlines

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the US Food and Drug Administration (FDA) has granted Priority Review designation for the Company's New Drug Application (NDA) for crofelemer 125 mg tablets for the proposed indication for ...

NCTechNews (press release) - Feb 7, 2012 (Raleigh, NC) Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the US Food and Drug Administration (FDA) has granted Priority Review designation for the Company's New Drug Application (NDA) for crofelemer 125 mg tablets for the proposed ...

(RTTNews.com) - Salix Pharmaceuticals Ltd. (SLXP) announced that the US Food and Drug Administration has granted Priority Review designation for the Company's New Drug Application or NDA for crofelemer 125 mg tablets for the proposed indication for the ...

Salix Pharmaceuticals Announces FDA Granting of Priority Review Designation ... MarketWatch (press release) - 20 hours ago RALEIGH, NC, Feb 07, 2012 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. /quotes/zigman/87125/quotes/nls/slxp SLXP -0.25% today announced that the US Food and Drug Administration (FDA) has granted Priority Review designation for the Company's New Drug ...

Reuters Key Development - Feb 7, 2012

Financial News Network Online - Jan 31, 2012 Salix Pharmaceuticals (NASDAQ:SLXP) shares have crossed bullishly above their 10-day moving average of $46.89 on a volume of 132K shares.

LocalizedUSA - Jan 30, 2012 Salix Pharmaceuticals (NASDAQ: SLXP) was downgraded by Stifel Nicolaus from a ?buy? rating to a ?hold? rating in a research note issued on Monday. Salix Pharmaceuticals Up 2.6% Since JMP Securities Downgraded One Week Ago (SLXP) - Financial News Network Online

A week ago, JMP Securities downgraded Salix Pharmaceuticals from Outperform to Market Perform. The shares closed at $47.29, or 2.6% over the $46.11 price of one week ago.

Salix Pharmaceuticals is Among the Companies in the Pharmaceuticals Industry ... Financial News Network Online - 10 hours ago We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength.

Salix Pharmaceuticals is Among the Companies in the Pharmaceuticals Industry ... Financial News Network Online - 10 hours ago We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength.

Jan 23, 2012 (SmarTrend(R) Upgrades/Downgrades via COMTEX) -- Salix Pharmaceuticals (SLXP) was downgraded from Outperform to Market Perform at JMP Securities today. Salix Pharmaceuticals (SLXP) Shares Downgraded to "Market Perform" by JMP ... - LocalizedUSA

Investment Analysts' Downgrades for January, 20th (SGMS, SLXP, SONO, SSD, STP ... LocalizedUSA - 49 minutes ago Scientific Games Corp (NASDAQ: SGMS) was downgraded by analysts at Brean Murray from a ?buy? rating to a ?hold? rating. They now have a $12.00 price target on the stock.

Salix Pharmaceuticals (NASDAQ: SLXP) was downgraded by equities research analysts at Stifel Nicolaus from a ?buy? rating to a ?hold? rating in a research note issued to investors on Friday.

| MUMBAI (Reuters) - Glenmark Pharmaceuticals Ltd (GLEN.NS) said on Friday it had received an interim order from a US arbitration panel against US-based Napo Pharamaceuticals Inc's termination of a collaboration pact for an HIV-associated diarrhoea ...

Jan 12, 2012 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Salix Pharmaceuticals (SLXP) on October 6th, 2011 at $30.67.